Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11458104 | MISSION PHARMACAL | Enteric coated tiopronin tablet |
Nov, 2038
(14 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
ODE*(ODE*) | Jun 28, 2026 |
Market Authorisation Date: 28 June, 2019
Treatment: A method of treating cystinuria by orally administering tiopronin with food to prevent cystine stone formation in adults and pediatric patients with severe homozygous cystinuria
Dosage: TABLET, DELAYED RELEASE;ORAL